Cargando…
Rapid Production of Human VEGF-A following Intradermal Injection of Modified VEGF-A mRNA Demonstrated by Cutaneous Microdialysis in the Rabbit and Pig In Vivo
Chemically modified mRNA is a novel, highly efficient, biocompatible modality for therapeutic protein expression that may overcome the challenges and safety concerns with current gene therapy strategies. We explored the efficiency of intradermally injected modified VEGF-A(165) mRNA (VEGF-A mRNA) for...
Autores principales: | Pehrsson, Susanne, Hölttä, Mikko, Linhardt, Gunilla, Danielson, Regina Fritsche, Carlsson, Leif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350593/ https://www.ncbi.nlm.nih.gov/pubmed/30766883 http://dx.doi.org/10.1155/2019/3915851 |
Ejemplares similares
-
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
por: Gan, Li-Ming, et al.
Publicado: (2019) -
Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing
por: Sun, Naidi, et al.
Publicado: (2018) -
Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
por: Carlsson, Leif, et al.
Publicado: (2018) -
An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent
por: Su, Er-Ning, et al.
Publicado: (2012) -
Exploring the mechanisms underpinning sweating: the development of a specialized ventilated capsule for use with intradermal microdialysis
por: Meade, Robert D., et al.
Publicado: (2016)